Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127178741 | 12717874 | 1 | I | 20160627 | 20160831 | 20160906 | 20160906 | EXP | CN-BAYER-2016-171025 | BAYER | 64.00 | YR | A | F | Y | 46.00000 | KG | 20160906 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127178741 | 12717874 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | 400 MG, QD | 2000 | MG | Y | BJ29128 | 21085 | 400 | MG | FILM-COATED TABLET | QD | ||
| 127178741 | 12717874 | 2 | SS | RIFAMPICIN | RIFAMPIN | 1 | Oral | 0.45 G, QD | 3 | G | 151203 | 0 | .45 | G | QD | ||||
| 127178741 | 12717874 | 3 | SS | ISONIAZID. | ISONIAZID | 1 | Oral | 300 MG, QD | 1800 | MG | 1410041 | 0 | 300 | MG | QD | ||||
| 127178741 | 12717874 | 4 | SS | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | Oral | 0.5 G, QD | 2.286 | G | 2160201 | 0 | .5 | G | QD | ||||
| 127178741 | 12717874 | 5 | SS | LORATADINE. | LORATADINE | 1 | UNK | 0 | |||||||||||
| 127178741 | 12717874 | 6 | SS | CALCIUM GLUCONATE. | CALCIUM GLUCONATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127178741 | 12717874 | 1 | Infection |
| 127178741 | 12717874 | 2 | Tuberculosis |
| 127178741 | 12717874 | 3 | Tuberculosis |
| 127178741 | 12717874 | 4 | Tuberculosis |
| 127178741 | 12717874 | 5 | Antiallergic therapy |
| 127178741 | 12717874 | 6 | Antiallergic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127178741 | 12717874 | OT |
| 127178741 | 12717874 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127178741 | 12717874 | Face oedema | |
| 127178741 | 12717874 | Pyrexia | |
| 127178741 | 12717874 | Rash | |
| 127178741 | 12717874 | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127178741 | 12717874 | 1 | 20160623 | 20160627 | 0 | |
| 127178741 | 12717874 | 2 | 20160622 | 20160627 | 0 | |
| 127178741 | 12717874 | 3 | 20160622 | 20160630 | 0 | |
| 127178741 | 12717874 | 4 | 20160624 | 20160630 | 0 | |
| 127178741 | 12717874 | 5 | 20160628 | 0 | ||
| 127178741 | 12717874 | 6 | 20160628 | 0 |